newsfilter
← Latest News
PR Newswire·

Braxia Scientific Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Expanded clinical infrastructure to support a growing portfolio of clinical trials of novel interventions and for drug discovery; 14 registered clinical trials in depression, led by Company CEO and Chief Medical and Scientific Officer, completed or